Biotech may be in trouble post-COVID–see WSJ here. Whether the glut of biotech real estate is a leading or trailing indicator is not answered, but I think it’s essential to understand what these data mean.
At my own institution, I watched as high-quality biotech space was repurposed as office modules–a massive waste of resources. If this trend is a leading indicator, it’s even more troubling because we still have a ton of public health challenges out there that remain without cures of even viable treatment.
Discoverers and Discoveries 